Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POISE-2: Clonidine and ASA in Noncardiac Surgery
NCT01082874Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Jul 2010
- Primary completion
- Mar 2014
- Modality
- Orthosteric Ligands
- Countries
- 23
01
Overview
Phase 3, randomised, double-blind trial of clonidine and aspirin in myocardial infarction (MI) and cardiovascular disease (CVD) (4 arms), sponsored by Hamilton Health Sciences. Primary endpoints: Composite of All-cause Mortality and Nonfatal Myocardial Infarction at 30 days and All-cause Mortality and Nonfatal Myocardial Infarction at 1 year. Started Jul 2010; status: completed.
02
Drugs
clonidineaspirin
03
Conditions
myocardial infarction (MI)cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT01082874.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01082874.